Short-term activation of PERK alleviates the progression of experimental non-alcoholic steatohepatitis

J Hepatol. 2023 Dec;79(6):e234-e236. doi: 10.1016/j.jhep.2023.05.036. Epub 2023 Jun 9.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Animals
  • Liver
  • Non-alcoholic Fatty Liver Disease*
  • eIF-2 Kinase* / metabolism

Substances

  • PERK kinase
  • eIF-2 Kinase